Incidence and outcomes of Clostridium difficile-associated disease in hematopoietic cell transplant recipients

International Journal of Hematology

Volumn 99, Issue 6, 2014, Pages 758-765

  Guddati, Achuta Kumar ^a   Kumar, Gagan ^b   Ahmed, Shahryar ^b   Ali, Muhammad ^b   Kumar, Nilay ^b   Hari, Parameswaran ^b   Venu, Nanda ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Clostridium difficile associated disease; Graft versus host disease; Hematopoietic stem cell transplant; Mortality

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ICD-9-CM; INTESTINE MUCOSA; INTESTINE PERFORATION; INTESTINE SURGERY; LENGTH OF STAY; LEUKEMIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEGACOLON; MORTALITY; MULTIPLE MYELOMA; PERITONITIS; TREATMENT INDICATION; UNITED STATES; ADOLESCENT; ADVERSE EFFECTS; COMORBIDITY; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GRAFT VS HOST DISEASE; INCIDENCE; MIDDLE AGED; OUTCOME ASSESSMENT; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; COMORBIDITY; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84905392499     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-014-1577-z     Document Type: Article

References (31)

1. van Kraaij MG, Dekker AW, Verdonck LF, van Loon AM, Vinje J, Koopmans MP, et al. Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transpl. 2000;26(3):299-303. (Pubitemid 30614410)
2. Bobak D, Arfons LM, Creger RJ, Lazarus HM. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transpl. 2008;42(11):705-13.
3. Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol. 2011;4(4):409-16.
4. Smith LC, Ratard R. Clostridium difficile hospitalizations in Louisiana: a 10 year review. J La State Med Soc. 2011;163(4):192-5.
5. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2010;8(1):17-26.
6. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis. 1993;17(1):109-13. (Pubitemid 23197574)
7. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol. 1991;12(6):345-8.
8. Ali M, Ananthakrishnan AN, Ahmad S, Kumar N, Kumar G, Saeian K. Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl. 2012.
9. Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008;103(9):2308-13.
10. Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, et al. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol. 2010;105(1):106-13.
11. Alonso CD, Treadway SB, Hanna DB, Huff CA, Neofytos D, Carroll KC, et al. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2011;54(8):1053-63.
12. Chakrabarti S, Lees A, Jones SG, Milligan DW. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transpl. 2000;26(8):871-6.
13. Avery R, Pohlman B, Adal K, Bolwell B, Goldman M, Kalaycio M, et al. High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transpl. 2000;25(1):67-9. (Pubitemid 30093158)
14. Tomblyn M, Gordon L, Singhal S, Tallman M, Williams S, Winter J, et al. Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea. Bone Marrow Transpl. 2002;30(8):517-9. (Pubitemid 35331718)
15. Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transpl. 1996;18(2):265-71. (Pubitemid 26283673)
16. Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology. 1994;107(5):1398-407. (Pubitemid 24328277)
17. Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Bona RD, Khan AM, et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transpl. 1999;23(10):1039-42. (Pubitemid 29250849)
18. Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transpl. 2012.
19. Chopra T, Chandrasekar P, Salimnia H, Heilbrun LK, Smith D, Alangaden GJ. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation. Clin Transpl. 2011;25(1):E82-7.
20. Dubberke ER, Butler AM, Yokoe DS, Mayer J, Hota B, Mangino JE, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010;31(10):1030-7.
21. Dubberke ER, Reske KA, Srivastava A, Sadhu J, Gatti R, Young RM, et al. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transpl. 2010;24(2):192-8.
22. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529-49.
23. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-41. (Pubitemid 41770164)
24. Dubberke ER, Butler AM, Nyazee HA, Reske KA, Yokoe DS, Mayer J, et al. The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections. Clin Infect Dis. 2011;53(1):20-5.
25. http://www.hcup-us.ahrq.gov/db/nation/nis/NIS-2009-INTRODUCTION.pdf. Accessed May 5 2012.
26. Dubberke ER, Reske KA, McDonald LC, Fraser VJ. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis. 2006;12(10):1576-9. (Pubitemid 44570903)
27. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.
28. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-10. (Pubitemid 32641789)
29. Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(4):976-83.
30. Arango JI, Restrepo A, Schneider DL, Callander NS, Ochoa-Bayona JL, Restrepo MI, et al. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transpl. 2006;37(5):517-21.
31. Junghanss C, Marr KA, Carter RA, Sandmaier BM, Maris MB, Maloney DG, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transpl: J Am Soc Blood Marrow Transpl. 2002;8(9):512-20. (Pubitemid 35174825)